This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
SureNano Science (CSE: SURE) launches FDA-aligned GLP toxicology program for obesity drug candidate GEP-44, partnering with LabCorp to advance toward a Phase I clinical trial in Australia. A major milestone in the GLP-1 race. #Biotech #GLP1
2026-06-11T20:00:41.573Z